| 3.2 |
9.5 |
GO:2000297 |
negative regulation of synapse maturation(GO:2000297) |
| 2.3 |
11.3 |
GO:0046684 |
response to pyrethroid(GO:0046684) |
| 2.0 |
8.2 |
GO:0007412 |
axon target recognition(GO:0007412) |
| 1.3 |
5.1 |
GO:0019355 |
nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process(GO:0034627) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
| 1.3 |
5.1 |
GO:0002175 |
protein localization to paranode region of axon(GO:0002175) |
| 1.2 |
7.2 |
GO:0032796 |
uropod organization(GO:0032796) |
| 1.1 |
5.5 |
GO:0097116 |
gephyrin clustering involved in postsynaptic density assembly(GO:0097116) |
| 1.1 |
3.3 |
GO:0050925 |
negative regulation of negative chemotaxis(GO:0050925) |
| 1.1 |
4.3 |
GO:0042938 |
dipeptide transport(GO:0042938) |
| 1.1 |
5.4 |
GO:1902474 |
positive regulation of protein localization to synapse(GO:1902474) |
| 1.0 |
3.1 |
GO:0044028 |
DNA hypomethylation(GO:0044028) hypomethylation of CpG island(GO:0044029) |
| 1.0 |
6.7 |
GO:1900194 |
negative regulation of oocyte maturation(GO:1900194) |
| 0.9 |
2.8 |
GO:0072092 |
ureteric bud invasion(GO:0072092) |
| 0.9 |
3.7 |
GO:0009414 |
response to water deprivation(GO:0009414) |
| 0.9 |
2.7 |
GO:0071677 |
positive regulation of mononuclear cell migration(GO:0071677) |
| 0.9 |
4.5 |
GO:0098735 |
positive regulation of the force of heart contraction(GO:0098735) |
| 0.9 |
2.7 |
GO:0033159 |
negative regulation of protein import into nucleus, translocation(GO:0033159) |
| 0.9 |
4.3 |
GO:0003376 |
sphingosine-1-phosphate signaling pathway(GO:0003376) sphingolipid mediated signaling pathway(GO:0090520) |
| 0.8 |
5.0 |
GO:0030643 |
cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
| 0.8 |
5.8 |
GO:2001199 |
negative regulation of dendritic cell differentiation(GO:2001199) |
| 0.8 |
2.5 |
GO:0002447 |
eosinophil activation involved in immune response(GO:0002278) eosinophil mediated immunity(GO:0002447) eosinophil degranulation(GO:0043308) |
| 0.8 |
4.1 |
GO:0007256 |
activation of JNKK activity(GO:0007256) |
| 0.8 |
2.5 |
GO:0071929 |
alpha-tubulin acetylation(GO:0071929) |
| 0.8 |
4.8 |
GO:2000304 |
positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
| 0.8 |
4.7 |
GO:0060040 |
retinal bipolar neuron differentiation(GO:0060040) |
| 0.8 |
2.3 |
GO:0097105 |
presynaptic membrane assembly(GO:0097105) |
| 0.7 |
11.9 |
GO:1900454 |
positive regulation of long term synaptic depression(GO:1900454) |
| 0.7 |
5.2 |
GO:1904217 |
regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
| 0.7 |
2.2 |
GO:0035864 |
response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
| 0.7 |
7.3 |
GO:0090315 |
negative regulation of protein targeting to membrane(GO:0090315) |
| 0.7 |
3.6 |
GO:0061002 |
negative regulation of dendritic spine morphogenesis(GO:0061002) |
| 0.7 |
2.8 |
GO:0008627 |
intrinsic apoptotic signaling pathway in response to osmotic stress(GO:0008627) |
| 0.7 |
2.1 |
GO:1900275 |
negative regulation of phospholipase C activity(GO:1900275) regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) |
| 0.7 |
2.7 |
GO:0006780 |
uroporphyrinogen III biosynthetic process(GO:0006780) |
| 0.7 |
15.3 |
GO:0090036 |
regulation of protein kinase C signaling(GO:0090036) |
| 0.7 |
3.3 |
GO:1903715 |
regulation of aerobic respiration(GO:1903715) |
| 0.6 |
2.5 |
GO:0036515 |
serotonergic neuron axon guidance(GO:0036515) |
| 0.6 |
1.8 |
GO:0034334 |
adherens junction maintenance(GO:0034334) |
| 0.6 |
1.2 |
GO:0014873 |
response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
| 0.6 |
2.4 |
GO:0035617 |
stress granule disassembly(GO:0035617) |
| 0.6 |
2.3 |
GO:0032512 |
regulation of protein phosphatase type 2B activity(GO:0032512) |
| 0.6 |
4.0 |
GO:0090394 |
negative regulation of excitatory postsynaptic potential(GO:0090394) |
| 0.5 |
2.2 |
GO:0061030 |
epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
| 0.5 |
2.2 |
GO:0046013 |
regulation of T cell homeostatic proliferation(GO:0046013) |
| 0.5 |
2.2 |
GO:0044861 |
protein transport into plasma membrane raft(GO:0044861) |
| 0.5 |
2.1 |
GO:0060083 |
smooth muscle contraction involved in micturition(GO:0060083) |
| 0.5 |
2.7 |
GO:1903361 |
protein localization to basolateral plasma membrane(GO:1903361) |
| 0.5 |
7.2 |
GO:2001223 |
negative regulation of neuron migration(GO:2001223) |
| 0.5 |
2.0 |
GO:0032289 |
central nervous system myelin formation(GO:0032289) cardiac cell fate specification(GO:0060912) |
| 0.5 |
0.5 |
GO:0043569 |
negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
| 0.5 |
2.4 |
GO:0021814 |
cell motility involved in cerebral cortex radial glia guided migration(GO:0021814) |
| 0.5 |
1.9 |
GO:2001106 |
regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001106) |
| 0.5 |
3.3 |
GO:0019227 |
neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
| 0.4 |
1.3 |
GO:0046340 |
diacylglycerol catabolic process(GO:0046340) |
| 0.4 |
1.8 |
GO:0051643 |
endoplasmic reticulum localization(GO:0051643) |
| 0.4 |
7.3 |
GO:0021542 |
dentate gyrus development(GO:0021542) |
| 0.4 |
1.7 |
GO:0071415 |
cellular response to caffeine(GO:0071313) cellular response to purine-containing compound(GO:0071415) |
| 0.4 |
2.1 |
GO:0018125 |
peptidyl-cysteine methylation(GO:0018125) |
| 0.4 |
3.6 |
GO:0098907 |
protein localization to M-band(GO:0036309) protein localization to T-tubule(GO:0036371) regulation of SA node cell action potential(GO:0098907) |
| 0.4 |
1.2 |
GO:0010636 |
positive regulation of mitochondrial fusion(GO:0010636) |
| 0.4 |
2.0 |
GO:0003105 |
negative regulation of glomerular filtration(GO:0003105) |
| 0.4 |
1.9 |
GO:0030242 |
pexophagy(GO:0030242) |
| 0.4 |
1.1 |
GO:0035582 |
sequestering of BMP in extracellular matrix(GO:0035582) |
| 0.4 |
1.5 |
GO:0097104 |
postsynaptic membrane assembly(GO:0097104) |
| 0.4 |
2.1 |
GO:0070863 |
positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
| 0.4 |
2.5 |
GO:0032811 |
negative regulation of gamma-aminobutyric acid secretion(GO:0014053) negative regulation of epinephrine secretion(GO:0032811) |
| 0.3 |
3.1 |
GO:0086036 |
regulation of cardiac muscle cell membrane potential(GO:0086036) |
| 0.3 |
4.1 |
GO:0070914 |
UV-damage excision repair(GO:0070914) |
| 0.3 |
1.0 |
GO:1904211 |
membrane protein proteolysis involved in retrograde protein transport, ER to cytosol(GO:1904211) |
| 0.3 |
2.2 |
GO:0006621 |
protein retention in ER lumen(GO:0006621) |
| 0.3 |
1.0 |
GO:0043456 |
regulation of pentose-phosphate shunt(GO:0043456) |
| 0.3 |
3.1 |
GO:0007379 |
segment specification(GO:0007379) |
| 0.3 |
2.2 |
GO:0032276 |
regulation of gonadotropin secretion(GO:0032276) |
| 0.3 |
1.2 |
GO:0046958 |
nonassociative learning(GO:0046958) |
| 0.3 |
1.2 |
GO:2000211 |
regulation of glutamate metabolic process(GO:2000211) |
| 0.3 |
0.9 |
GO:0014809 |
regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion(GO:0014809) |
| 0.3 |
2.6 |
GO:0048149 |
behavioral response to ethanol(GO:0048149) |
| 0.3 |
1.5 |
GO:0033762 |
response to glucagon(GO:0033762) |
| 0.3 |
0.6 |
GO:0070488 |
neutrophil aggregation(GO:0070488) |
| 0.3 |
2.2 |
GO:1903847 |
regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
| 0.3 |
1.7 |
GO:0061718 |
NADH regeneration(GO:0006735) canonical glycolysis(GO:0061621) glycolytic process through glucose-1-phosphate(GO:0061622) glucose catabolic process to pyruvate(GO:0061718) |
| 0.3 |
0.8 |
GO:0048162 |
preantral ovarian follicle growth(GO:0001546) multi-layer follicle stage(GO:0048162) |
| 0.3 |
2.1 |
GO:0002674 |
negative regulation of acute inflammatory response(GO:0002674) |
| 0.3 |
4.4 |
GO:0046069 |
cGMP catabolic process(GO:0046069) |
| 0.3 |
2.6 |
GO:0031665 |
negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
| 0.3 |
5.2 |
GO:0048026 |
positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
| 0.3 |
0.5 |
GO:0070212 |
protein poly-ADP-ribosylation(GO:0070212) |
| 0.3 |
1.3 |
GO:0006543 |
glutamine catabolic process(GO:0006543) |
| 0.3 |
4.1 |
GO:0050966 |
detection of mechanical stimulus involved in sensory perception of pain(GO:0050966) |
| 0.3 |
0.8 |
GO:0016115 |
terpenoid catabolic process(GO:0016115) |
| 0.3 |
1.5 |
GO:0051694 |
pointed-end actin filament capping(GO:0051694) |
| 0.2 |
0.5 |
GO:0033860 |
regulation of NAD(P)H oxidase activity(GO:0033860) |
| 0.2 |
1.0 |
GO:0060158 |
phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
| 0.2 |
1.0 |
GO:0019919 |
peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
| 0.2 |
1.0 |
GO:0042796 |
snRNA transcription from RNA polymerase III promoter(GO:0042796) |
| 0.2 |
2.6 |
GO:1902018 |
negative regulation of cilium assembly(GO:1902018) |
| 0.2 |
0.5 |
GO:0002069 |
columnar/cuboidal epithelial cell maturation(GO:0002069) |
| 0.2 |
0.7 |
GO:0051031 |
tRNA transport(GO:0051031) |
| 0.2 |
2.3 |
GO:2000489 |
hepatic stellate cell activation(GO:0035733) regulation of hepatic stellate cell activation(GO:2000489) |
| 0.2 |
1.2 |
GO:0034393 |
positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
| 0.2 |
0.7 |
GO:0045014 |
carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) |
| 0.2 |
5.5 |
GO:0060749 |
mammary gland alveolus development(GO:0060749) mammary gland lobule development(GO:0061377) |
| 0.2 |
0.5 |
GO:0032714 |
negative regulation of interleukin-5 production(GO:0032714) regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032829) |
| 0.2 |
0.7 |
GO:0016056 |
photoreceptor cell morphogenesis(GO:0008594) rhodopsin mediated signaling pathway(GO:0016056) post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
| 0.2 |
0.9 |
GO:0055099 |
response to high density lipoprotein particle(GO:0055099) |
| 0.2 |
0.9 |
GO:0099624 |
regulation of atrial cardiac muscle cell membrane repolarization(GO:0060372) atrial cardiac muscle cell membrane repolarization(GO:0099624) |
| 0.2 |
0.9 |
GO:0072137 |
condensed mesenchymal cell proliferation(GO:0072137) |
| 0.2 |
9.4 |
GO:0061001 |
regulation of dendritic spine morphogenesis(GO:0061001) |
| 0.2 |
0.9 |
GO:0021564 |
glossopharyngeal nerve development(GO:0021563) vagus nerve development(GO:0021564) |
| 0.2 |
2.1 |
GO:0014051 |
gamma-aminobutyric acid secretion(GO:0014051) |
| 0.2 |
0.6 |
GO:0009223 |
pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
| 0.2 |
1.6 |
GO:0071732 |
cellular response to nitric oxide(GO:0071732) |
| 0.2 |
0.8 |
GO:0034184 |
positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
| 0.2 |
1.0 |
GO:0010724 |
regulation of definitive erythrocyte differentiation(GO:0010724) |
| 0.2 |
1.2 |
GO:1903056 |
mammillary body development(GO:0021767) mammillary axonal complex development(GO:0061373) regulation of lens fiber cell differentiation(GO:1902746) positive regulation of lens fiber cell differentiation(GO:1902748) regulation of melanosome organization(GO:1903056) |
| 0.2 |
4.2 |
GO:0071625 |
vocalization behavior(GO:0071625) |
| 0.2 |
3.0 |
GO:1902260 |
negative regulation of delayed rectifier potassium channel activity(GO:1902260) negative regulation of voltage-gated potassium channel activity(GO:1903817) |
| 0.2 |
1.0 |
GO:1901678 |
iron coordination entity transport(GO:1901678) |
| 0.2 |
0.2 |
GO:0031587 |
positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031587) |
| 0.2 |
1.2 |
GO:0072321 |
chaperone-mediated protein transport(GO:0072321) |
| 0.2 |
0.6 |
GO:0045162 |
clustering of voltage-gated sodium channels(GO:0045162) |
| 0.2 |
0.9 |
GO:0031547 |
brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
| 0.2 |
0.6 |
GO:0097167 |
circadian regulation of translation(GO:0097167) |
| 0.2 |
1.7 |
GO:2000650 |
negative regulation of sodium ion transmembrane transporter activity(GO:2000650) |
| 0.2 |
0.6 |
GO:2000078 |
positive regulation of type B pancreatic cell development(GO:2000078) |
| 0.2 |
1.1 |
GO:0097151 |
positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
| 0.2 |
2.4 |
GO:0014047 |
glutamate secretion(GO:0014047) |
| 0.2 |
2.1 |
GO:1900383 |
regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
| 0.2 |
1.2 |
GO:0048251 |
elastic fiber assembly(GO:0048251) |
| 0.2 |
2.0 |
GO:0051601 |
exocyst localization(GO:0051601) |
| 0.2 |
0.8 |
GO:0005513 |
detection of calcium ion(GO:0005513) |
| 0.2 |
2.3 |
GO:0045671 |
negative regulation of osteoclast differentiation(GO:0045671) |
| 0.2 |
0.6 |
GO:0060753 |
regulation of mast cell chemotaxis(GO:0060753) |
| 0.2 |
1.3 |
GO:0032020 |
ISG15-protein conjugation(GO:0032020) |
| 0.2 |
0.8 |
GO:0001778 |
plasma membrane repair(GO:0001778) |
| 0.2 |
2.9 |
GO:0021860 |
pyramidal neuron development(GO:0021860) |
| 0.2 |
3.2 |
GO:0035024 |
negative regulation of Rho protein signal transduction(GO:0035024) |
| 0.2 |
3.9 |
GO:0010043 |
response to zinc ion(GO:0010043) |
| 0.2 |
0.5 |
GO:0045199 |
maintenance of epithelial cell apical/basal polarity(GO:0045199) |
| 0.2 |
4.4 |
GO:0050775 |
positive regulation of dendrite morphogenesis(GO:0050775) |
| 0.1 |
1.0 |
GO:0043046 |
DNA methylation involved in gamete generation(GO:0043046) |
| 0.1 |
0.3 |
GO:2000601 |
positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
| 0.1 |
4.0 |
GO:0048791 |
calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
| 0.1 |
0.4 |
GO:0036092 |
phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
| 0.1 |
1.3 |
GO:0071420 |
cellular response to histamine(GO:0071420) |
| 0.1 |
0.4 |
GO:0032792 |
negative regulation of CREB transcription factor activity(GO:0032792) |
| 0.1 |
1.3 |
GO:0048537 |
mucosal-associated lymphoid tissue development(GO:0048537) Peyer's patch development(GO:0048541) |
| 0.1 |
1.6 |
GO:0071225 |
cellular response to muramyl dipeptide(GO:0071225) |
| 0.1 |
4.0 |
GO:0003301 |
physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
| 0.1 |
6.6 |
GO:0008542 |
visual learning(GO:0008542) |
| 0.1 |
7.4 |
GO:1900006 |
positive regulation of dendrite development(GO:1900006) |
| 0.1 |
0.6 |
GO:0000160 |
phosphorelay signal transduction system(GO:0000160) |
| 0.1 |
0.3 |
GO:0072344 |
rescue of stalled ribosome(GO:0072344) |
| 0.1 |
0.7 |
GO:0036438 |
maintenance of lens transparency(GO:0036438) |
| 0.1 |
3.1 |
GO:0007617 |
mating behavior(GO:0007617) multi-organism reproductive behavior(GO:0044705) |
| 0.1 |
4.1 |
GO:0034723 |
DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
| 0.1 |
1.2 |
GO:0031115 |
negative regulation of microtubule polymerization(GO:0031115) |
| 0.1 |
0.5 |
GO:0070537 |
histone H2A K63-linked deubiquitination(GO:0070537) |
| 0.1 |
13.6 |
GO:0006342 |
chromatin silencing(GO:0006342) |
| 0.1 |
1.7 |
GO:1990440 |
positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
| 0.1 |
0.3 |
GO:0045409 |
negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
| 0.1 |
0.4 |
GO:0007158 |
neuron cell-cell adhesion(GO:0007158) |
| 0.1 |
0.5 |
GO:1900424 |
regulation of defense response to bacterium(GO:1900424) |
| 0.1 |
0.7 |
GO:1903423 |
positive regulation of synaptic vesicle transport(GO:1902805) positive regulation of synaptic vesicle recycling(GO:1903423) |
| 0.1 |
0.6 |
GO:0050912 |
detection of chemical stimulus involved in sensory perception(GO:0050907) detection of chemical stimulus involved in sensory perception of taste(GO:0050912) |
| 0.1 |
9.6 |
GO:0006334 |
nucleosome assembly(GO:0006334) |
| 0.1 |
1.1 |
GO:0043084 |
penile erection(GO:0043084) |
| 0.1 |
0.6 |
GO:0060287 |
epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
| 0.1 |
0.8 |
GO:0097039 |
protein linear polyubiquitination(GO:0097039) |
| 0.1 |
1.0 |
GO:0071318 |
cellular response to ATP(GO:0071318) |
| 0.1 |
0.3 |
GO:0010936 |
negative regulation of macrophage cytokine production(GO:0010936) |
| 0.1 |
0.7 |
GO:0032329 |
serine transport(GO:0032329) |
| 0.1 |
2.5 |
GO:0032011 |
ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
| 0.1 |
1.4 |
GO:0036010 |
protein localization to endosome(GO:0036010) |
| 0.1 |
6.4 |
GO:0080171 |
lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
| 0.1 |
2.2 |
GO:0031290 |
retinal ganglion cell axon guidance(GO:0031290) |
| 0.1 |
0.4 |
GO:1902224 |
cellular ketone body metabolic process(GO:0046950) ketone body metabolic process(GO:1902224) |
| 0.1 |
0.8 |
GO:0046036 |
GTP biosynthetic process(GO:0006183) CTP biosynthetic process(GO:0006241) CTP metabolic process(GO:0046036) |
| 0.1 |
1.0 |
GO:0048488 |
synaptic vesicle endocytosis(GO:0048488) |
| 0.1 |
0.4 |
GO:0045605 |
negative regulation of epidermal cell differentiation(GO:0045605) |
| 0.1 |
2.5 |
GO:0016079 |
synaptic vesicle exocytosis(GO:0016079) |
| 0.1 |
1.1 |
GO:0035898 |
parathyroid hormone secretion(GO:0035898) |
| 0.1 |
3.5 |
GO:0045773 |
positive regulation of axon extension(GO:0045773) |
| 0.1 |
0.8 |
GO:0007413 |
axonal fasciculation(GO:0007413) |
| 0.1 |
0.5 |
GO:0071712 |
ER-associated misfolded protein catabolic process(GO:0071712) |
| 0.1 |
0.6 |
GO:0061635 |
regulation of protein complex stability(GO:0061635) |
| 0.1 |
0.4 |
GO:2001045 |
closure of optic fissure(GO:0061386) negative regulation of integrin-mediated signaling pathway(GO:2001045) |
| 0.1 |
0.6 |
GO:0060267 |
positive regulation of respiratory burst(GO:0060267) |
| 0.1 |
0.4 |
GO:0042276 |
error-prone translesion synthesis(GO:0042276) |
| 0.1 |
1.5 |
GO:0000301 |
retrograde transport, vesicle recycling within Golgi(GO:0000301) |
| 0.1 |
3.8 |
GO:0048278 |
vesicle docking(GO:0048278) |
| 0.1 |
0.5 |
GO:0071955 |
recycling endosome to Golgi transport(GO:0071955) |
| 0.1 |
0.6 |
GO:0006620 |
posttranslational protein targeting to membrane(GO:0006620) |
| 0.1 |
1.7 |
GO:0006415 |
translational termination(GO:0006415) |
| 0.1 |
0.7 |
GO:0061469 |
regulation of type B pancreatic cell proliferation(GO:0061469) |
| 0.1 |
3.2 |
GO:0006376 |
mRNA splice site selection(GO:0006376) |
| 0.1 |
0.6 |
GO:0033147 |
negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
| 0.1 |
0.9 |
GO:0021979 |
hypothalamus cell differentiation(GO:0021979) |
| 0.1 |
0.4 |
GO:0035331 |
negative regulation of hippo signaling(GO:0035331) |
| 0.1 |
0.2 |
GO:0002051 |
osteoblast fate commitment(GO:0002051) |
| 0.1 |
0.3 |
GO:0000098 |
sulfur amino acid catabolic process(GO:0000098) |
| 0.1 |
0.2 |
GO:0015882 |
L-ascorbic acid transport(GO:0015882) transepithelial L-ascorbic acid transport(GO:0070904) |
| 0.1 |
1.1 |
GO:0007263 |
nitric oxide mediated signal transduction(GO:0007263) |
| 0.1 |
1.3 |
GO:0010591 |
regulation of lamellipodium assembly(GO:0010591) |
| 0.1 |
1.6 |
GO:2000272 |
negative regulation of receptor activity(GO:2000272) |
| 0.1 |
0.6 |
GO:0031848 |
protection from non-homologous end joining at telomere(GO:0031848) |
| 0.1 |
2.5 |
GO:0003333 |
amino acid transmembrane transport(GO:0003333) |
| 0.1 |
0.5 |
GO:1901096 |
regulation of autophagosome maturation(GO:1901096) |
| 0.1 |
2.3 |
GO:0016601 |
Rac protein signal transduction(GO:0016601) |
| 0.1 |
1.3 |
GO:0010758 |
regulation of macrophage chemotaxis(GO:0010758) |
| 0.1 |
1.0 |
GO:0032967 |
positive regulation of collagen biosynthetic process(GO:0032967) |
| 0.1 |
1.9 |
GO:0048873 |
homeostasis of number of cells within a tissue(GO:0048873) |
| 0.1 |
1.7 |
GO:0010107 |
potassium ion import(GO:0010107) |
| 0.1 |
0.7 |
GO:0032469 |
endoplasmic reticulum calcium ion homeostasis(GO:0032469) |
| 0.1 |
2.7 |
GO:0007257 |
activation of JUN kinase activity(GO:0007257) |
| 0.1 |
0.7 |
GO:0031268 |
pseudopodium organization(GO:0031268) |
| 0.1 |
1.1 |
GO:0001539 |
cilium or flagellum-dependent cell motility(GO:0001539) cilium-dependent cell motility(GO:0060285) |
| 0.1 |
0.7 |
GO:0044872 |
lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
| 0.1 |
4.0 |
GO:0031110 |
regulation of microtubule polymerization or depolymerization(GO:0031110) |
| 0.1 |
1.0 |
GO:0043968 |
histone H2A acetylation(GO:0043968) |
| 0.1 |
0.7 |
GO:0030322 |
stabilization of membrane potential(GO:0030322) |
| 0.1 |
0.6 |
GO:1904424 |
regulation of GTP binding(GO:1904424) |
| 0.1 |
0.2 |
GO:0032570 |
response to progesterone(GO:0032570) |
| 0.1 |
0.6 |
GO:0031017 |
exocrine pancreas development(GO:0031017) |
| 0.1 |
0.5 |
GO:1901030 |
positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901030) |
| 0.1 |
0.3 |
GO:1902285 |
semaphorin-plexin signaling pathway involved in neuron projection guidance(GO:1902285) semaphorin-plexin signaling pathway involved in axon guidance(GO:1902287) |
| 0.1 |
2.1 |
GO:0007218 |
neuropeptide signaling pathway(GO:0007218) |
| 0.1 |
0.9 |
GO:0002091 |
negative regulation of receptor internalization(GO:0002091) |
| 0.1 |
3.9 |
GO:0007156 |
homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
| 0.1 |
0.2 |
GO:0030070 |
insulin processing(GO:0030070) |
| 0.1 |
0.2 |
GO:0051195 |
negative regulation of glycolytic process(GO:0045820) negative regulation of cofactor metabolic process(GO:0051195) negative regulation of coenzyme metabolic process(GO:0051198) |
| 0.1 |
0.9 |
GO:0060712 |
spongiotrophoblast layer development(GO:0060712) |
| 0.1 |
1.1 |
GO:1901381 |
positive regulation of potassium ion transmembrane transport(GO:1901381) |
| 0.1 |
0.4 |
GO:0030718 |
germ-line stem cell population maintenance(GO:0030718) |
| 0.1 |
1.7 |
GO:0008045 |
motor neuron axon guidance(GO:0008045) |
| 0.1 |
0.9 |
GO:0016578 |
histone deubiquitination(GO:0016578) |
| 0.1 |
0.4 |
GO:0035520 |
monoubiquitinated protein deubiquitination(GO:0035520) |
| 0.1 |
0.4 |
GO:1900037 |
regulation of cellular response to hypoxia(GO:1900037) |
| 0.1 |
0.4 |
GO:0023019 |
signal transduction involved in regulation of gene expression(GO:0023019) |
| 0.1 |
0.2 |
GO:0035616 |
histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
| 0.1 |
0.7 |
GO:1903541 |
regulation of exosomal secretion(GO:1903541) positive regulation of exosomal secretion(GO:1903543) |
| 0.1 |
0.1 |
GO:0045342 |
MHC class II biosynthetic process(GO:0045342) regulation of MHC class II biosynthetic process(GO:0045346) negative regulation of MHC class II biosynthetic process(GO:0045347) |
| 0.1 |
0.6 |
GO:0006107 |
oxaloacetate metabolic process(GO:0006107) |
| 0.1 |
0.2 |
GO:1901837 |
negative regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901837) |
| 0.1 |
0.9 |
GO:0002495 |
antigen processing and presentation of peptide antigen via MHC class II(GO:0002495) antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002504) |
| 0.0 |
0.1 |
GO:0002636 |
positive regulation of germinal center formation(GO:0002636) |
| 0.0 |
1.3 |
GO:0048662 |
negative regulation of smooth muscle cell proliferation(GO:0048662) |
| 0.0 |
2.7 |
GO:0072384 |
organelle transport along microtubule(GO:0072384) |
| 0.0 |
0.6 |
GO:0034331 |
cell junction maintenance(GO:0034331) |
| 0.0 |
0.9 |
GO:0048268 |
clathrin coat assembly(GO:0048268) |
| 0.0 |
0.5 |
GO:0090073 |
positive regulation of protein homodimerization activity(GO:0090073) |
| 0.0 |
0.4 |
GO:0006654 |
phosphatidic acid biosynthetic process(GO:0006654) phosphatidic acid metabolic process(GO:0046473) |
| 0.0 |
1.3 |
GO:0000381 |
regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
| 0.0 |
0.6 |
GO:0019835 |
cytolysis(GO:0019835) |
| 0.0 |
0.7 |
GO:1902187 |
negative regulation of viral release from host cell(GO:1902187) |
| 0.0 |
1.3 |
GO:0007041 |
lysosomal transport(GO:0007041) |
| 0.0 |
0.3 |
GO:0032790 |
ribosome disassembly(GO:0032790) |
| 0.0 |
0.2 |
GO:0071894 |
histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
| 0.0 |
2.2 |
GO:0051865 |
protein autoubiquitination(GO:0051865) |
| 0.0 |
2.1 |
GO:0030968 |
endoplasmic reticulum unfolded protein response(GO:0030968) |
| 0.0 |
0.8 |
GO:0034198 |
cellular response to amino acid starvation(GO:0034198) |
| 0.0 |
1.4 |
GO:0031648 |
protein destabilization(GO:0031648) |
| 0.0 |
0.2 |
GO:0021993 |
initiation of neural tube closure(GO:0021993) |
| 0.0 |
0.8 |
GO:0006301 |
postreplication repair(GO:0006301) |
| 0.0 |
0.6 |
GO:0034389 |
lipid particle organization(GO:0034389) |
| 0.0 |
2.7 |
GO:0051101 |
regulation of DNA binding(GO:0051101) |
| 0.0 |
0.8 |
GO:0008347 |
glial cell migration(GO:0008347) |
| 0.0 |
1.1 |
GO:0006584 |
catecholamine metabolic process(GO:0006584) catechol-containing compound metabolic process(GO:0009712) |
| 0.0 |
0.3 |
GO:0048681 |
negative regulation of axon regeneration(GO:0048681) |
| 0.0 |
1.3 |
GO:0050885 |
neuromuscular process controlling balance(GO:0050885) |
| 0.0 |
0.5 |
GO:0090161 |
Golgi ribbon formation(GO:0090161) |
| 0.0 |
0.2 |
GO:0035428 |
hexose transmembrane transport(GO:0035428) |
| 0.0 |
0.1 |
GO:0006432 |
phenylalanyl-tRNA aminoacylation(GO:0006432) |
| 0.0 |
0.1 |
GO:0097494 |
regulation of vesicle size(GO:0097494) |
| 0.0 |
0.7 |
GO:1904030 |
negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
| 0.0 |
0.1 |
GO:0007290 |
spermatid nucleus elongation(GO:0007290) |
| 0.0 |
0.4 |
GO:0045840 |
positive regulation of mitotic nuclear division(GO:0045840) |
| 0.0 |
2.7 |
GO:0098792 |
xenophagy(GO:0098792) |
| 0.0 |
0.4 |
GO:0035518 |
histone H2A monoubiquitination(GO:0035518) |
| 0.0 |
0.2 |
GO:0032261 |
purine nucleotide salvage(GO:0032261) IMP salvage(GO:0032264) |
| 0.0 |
0.2 |
GO:0060088 |
auditory receptor cell stereocilium organization(GO:0060088) |
| 0.0 |
0.1 |
GO:0071921 |
establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
| 0.0 |
0.1 |
GO:2001168 |
regulation of histone H2B ubiquitination(GO:2001166) positive regulation of histone H2B ubiquitination(GO:2001168) |
| 0.0 |
0.3 |
GO:0046085 |
adenosine metabolic process(GO:0046085) |
| 0.0 |
0.8 |
GO:0048168 |
regulation of neuronal synaptic plasticity(GO:0048168) |
| 0.0 |
0.4 |
GO:0021796 |
cerebral cortex regionalization(GO:0021796) |
| 0.0 |
0.2 |
GO:0034219 |
carbohydrate transmembrane transport(GO:0034219) |
| 0.0 |
0.5 |
GO:0006829 |
zinc II ion transport(GO:0006829) |
| 0.0 |
0.1 |
GO:0090298 |
negative regulation of mitochondrial DNA replication(GO:0090298) negative regulation of mitochondrial DNA metabolic process(GO:1901859) |
| 0.0 |
0.1 |
GO:0019372 |
lipoxygenase pathway(GO:0019372) |
| 0.0 |
0.3 |
GO:0019368 |
fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
| 0.0 |
0.1 |
GO:0060971 |
embryonic heart tube left/right pattern formation(GO:0060971) |
| 0.0 |
0.4 |
GO:0097120 |
receptor localization to synapse(GO:0097120) |
| 0.0 |
0.6 |
GO:0031146 |
SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
| 0.0 |
0.2 |
GO:0034453 |
microtubule anchoring(GO:0034453) |
| 0.0 |
2.1 |
GO:0051297 |
centrosome organization(GO:0051297) |
| 0.0 |
0.2 |
GO:0008088 |
axo-dendritic transport(GO:0008088) |
| 0.0 |
0.7 |
GO:0007520 |
myoblast fusion(GO:0007520) |
| 0.0 |
0.4 |
GO:0070979 |
protein K11-linked ubiquitination(GO:0070979) |
| 0.0 |
0.2 |
GO:0045721 |
negative regulation of gluconeogenesis(GO:0045721) |
| 0.0 |
0.4 |
GO:0006110 |
regulation of glycolytic process(GO:0006110) |
| 0.0 |
0.1 |
GO:0033148 |
positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
| 0.0 |
0.1 |
GO:0046928 |
regulation of neurotransmitter secretion(GO:0046928) |
| 0.0 |
1.1 |
GO:0006888 |
ER to Golgi vesicle-mediated transport(GO:0006888) |
| 0.0 |
0.2 |
GO:0032528 |
microvillus assembly(GO:0030033) microvillus organization(GO:0032528) |
| 0.0 |
0.2 |
GO:0007616 |
short-term memory(GO:0007614) long-term memory(GO:0007616) |
| 0.0 |
0.2 |
GO:0090042 |
tubulin deacetylation(GO:0090042) |
| 0.0 |
0.4 |
GO:0043029 |
T cell homeostasis(GO:0043029) |
| 0.0 |
0.2 |
GO:0060670 |
branching involved in labyrinthine layer morphogenesis(GO:0060670) |
| 0.0 |
0.2 |
GO:0032367 |
intracellular cholesterol transport(GO:0032367) |
| 0.0 |
0.5 |
GO:0046580 |
negative regulation of Ras protein signal transduction(GO:0046580) negative regulation of small GTPase mediated signal transduction(GO:0051058) |
| 0.0 |
0.1 |
GO:1900864 |
mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
| 0.0 |
0.1 |
GO:0009404 |
toxin metabolic process(GO:0009404) |
| 0.0 |
0.1 |
GO:0046543 |
development of secondary female sexual characteristics(GO:0046543) |
| 0.0 |
0.3 |
GO:0010172 |
embryonic body morphogenesis(GO:0010172) |
| 0.0 |
0.4 |
GO:0018107 |
peptidyl-threonine phosphorylation(GO:0018107) |
| 0.0 |
0.1 |
GO:1902268 |
negative regulation of polyamine transmembrane transport(GO:1902268) |
| 0.0 |
1.5 |
GO:0006497 |
protein lipidation(GO:0006497) |
| 0.0 |
1.5 |
GO:0050770 |
regulation of axonogenesis(GO:0050770) |
| 0.0 |
1.3 |
GO:0006813 |
potassium ion transport(GO:0006813) |
| 0.0 |
0.7 |
GO:0002687 |
positive regulation of leukocyte migration(GO:0002687) |
| 0.0 |
0.6 |
GO:0030433 |
ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) |
| 0.0 |
0.4 |
GO:0009247 |
glycolipid biosynthetic process(GO:0009247) |
| 0.0 |
0.1 |
GO:1901409 |
regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
| 0.0 |
0.4 |
GO:0000460 |
maturation of 5.8S rRNA(GO:0000460) |
| 0.0 |
0.6 |
GO:0030518 |
intracellular steroid hormone receptor signaling pathway(GO:0030518) |
| 0.0 |
0.1 |
GO:0046322 |
very long-chain fatty acid catabolic process(GO:0042760) negative regulation of fatty acid oxidation(GO:0046322) |
